Treating
Cancers
Treating
Cancers
Treating
Cancers
In Companion
Animals
In Companion
Animals
In Companion
Animals
We develop novel, off-the shelf, as well as patient tailored immunotherapies for solid cancers.
Our belief is that the study and treatment of naturally developing cancer in man’s best friend can yield effective therapeutic solutions for humans as well.
New Therapeutics For Use in Dogs Our cancer therapies are on their way to clinical trials for use in dogs with solid tumors. If your pet is ill, have your veterinarian get in touch.
New Therapeutics For Use in Dogs
Our cancer therapies are on their way to clinical trials for use in dogs with solid tumors. If your pet is ill, have your veterinarian get in touch.
New Therapeutics For Use in Dogs
Our cancer therapies are on their way to clinical trials for use in dogs with solid tumors. If your pet is ill, have your veterinarian get in touch.
Over 200 million dogs & 200 million cats live in Europe and US, and their guardians increasingly see them as family.
Over 200 million dogs & 200 million cats live in Europe and US, and their guardians increasingly see them as family.
Over 200 million dogs & 200 million cats live in Europe and US, and their guardians increasingly see them as family.
Cancer is the #1 cause of death in dogs & cats, but still veterinary medicine is decades behind human medicine. Pet owners want better therapies for their four-legged family member.
Cancer is the #1 cause of death in dogs & cats, but still veterinary medicine is decades behind human medicine. Pet owners want better therapies for their four-legged family member.
Cancer is the #1 cause of death in dogs & cats, but still veterinary medicine is decades behind human medicine. Pet owners want better therapies for their four-legged family member.
Timing is right for introducing therapeutic solutions to manage hard-to-treat cancers in companion animals
Timing is right for introducing therapeutic solutions to manage hard-to-treat cancers in companion animals
Timing is right for introducing new therapy solutions to therapeutic solutions to manage hard-to-treat cancers in companion animals
"Working with Alv B and their dedicated veterinary partners has given us hope. Their innovative treatment protocol represents a new frontier in cancer care for our pets."
Cocker Spaniel Patient
Joy's Owner
"Working with Alv B and their dedicated veterinary partners has given us hope. Their innovative treatment protocol represents a new frontier in cancer care for our pets."
Cocker Spaniel Patient
Joy's Owner
"Working with Alv B and their dedicated veterinary partners has given us hope. Their innovative treatment protocol represents a new frontier in cancer care for our pets."
Cocker Spaniel Patient
Joy's Owner
"Working with Alv B and their dedicated veterinary partners has given us hope. Their innovative treatment protocol represents a new frontier in cancer care for our pets."
Cocker Spaniel Patient
Joy's Owner
Alv B AS is a Norwegian biotech company that develops cutting-edge, cost-effective cancer treatments for dogs. We benefit from a forward-thinking team well-versed in the latest advances in cancer research on humans, as well as dogs.
Four Decades
Of Veterinary Oncology experience
Four Patent Families
First granted
First Therapy
Already being tested in dogs
Our Approach
Our Approach
Our Approach
Comparative Oncology
We believe that the study of naturally developing cancers in man's best friend can provide significant medical advances for humans as well. Our veterinary cancer research provides valuable insights for both species.
Comparative Oncology
We believe that the study of naturally developing cancers in man's best friend can provide significant medical advances for humans as well. Our veterinary cancer research provides valuable insights for both species.
Comparative Oncology
We believe that the study of naturally developing cancers in man's best friend can provide significant medical advances for humans as well. Our veterinary cancer research provides valuable insights for both species.
Clinical Development
Our cancer therapies are on their way to randomized clinical trials for use in dogs with solid tumors. Our cross-functional team within science, medical, technical and regulatory expertise leads our efforts.
Clinical Development
Our cancer therapies are on their way to randomized clinical trials for use in dogs with solid tumors. Our cross-functional team within science, medical, technical and regulatory expertise leads our efforts.
Clinical Development
Our cancer therapies are on their way to randomized clinical trials for use in dogs with solid tumors. Our cross-functional team within science, medical, technical and regulatory expertise leads our efforts.
Research Collaboration
We are expanding rapidly and actively seeking partnerships with both public and private organizations. By joining forces with veterinary clinics, academic institutions, and research centers, we seek to accelerate cancer treatment innovation.
Research Collaboration
We are expanding rapidly and actively seeking partnerships with both public and private organizations. By joining forces with veterinary clinics, academic institutions, and research centers, we seek to accelerate cancer treatment innovation.
Research Collaboration
We are expanding rapidly and actively seeking partnerships with both public and private organizations. By joining forces with veterinary clinics, academic institutions, and research centers, we seek to accelerate cancer treatment innovation.
"Seeing how our innovative immunotherapy protocols are giving hope to pet owners facing cancer diagnoses is what drives our work. We're bridging the gap between human and veterinary oncology for better outcomes."
Dr. Lars Moe
Chief Medical Officer
Latest News
Latest News
Latest News
Today Dogs, Tomorrow Humans.
Through development of new treatment methods, research and data products will Alv B create value for our shareholders.
Today Dogs, Tomorrow Humans.
Through development of new treatment methods, research and data products will Alv B create value for our shareholders.
Today Dogs, Tomorrow Humans.
Through development of new treatment methods, research and data products will Alv B create value for our shareholders.